AIDSVAX B/E Placebo
Sponsors
U.S. Army Medical Research and Development Command
Conditions
HIV Infections
Phase 2
Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144
NCT01435135
Start: 2012-04-30End: 2021-07-31Target: 162Updated: 2020-11-03
Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E
NCT01931358
Start: 2013-09-24End: 2021-12-31Target: 360Updated: 2021-03-26
Study of Immune Responses Induced by a HIV Vaccine
NCT01933685
Start: 2014-07-03End: 2020-05-31Target: 40Updated: 2019-09-19